Medications & Supplements/Prescription Drugs

Accord Levothyroxine Sodium Tablets Recalled for Subpotency

Agency Publication Date: November 29, 2024

Summary

Accord Healthcare, Inc. is recalling one lot of Levothyroxine Sodium Tablets (75 mcg), used to treat hypothyroidism, because the medication was found to be subpotent. This means the tablets contain less than the required amount of active medication. If you are taking this medication, you should consult your healthcare provider or pharmacist as your dose may need to be adjusted or replaced.

Risk

Taking a subpotent dose of levothyroxine can lead to under-treatment of thyroid conditions, potentially causing symptoms like fatigue, weight gain, depression, and sensitivity to cold.

What You Should Do

This recall affects Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) sold in 1000-count bottles under NDC 16729-449-17.
Check the label of your prescription bottle for lot number D2300191 with an expiration date of 12/31/2025 to determine if your medication is part of the recall.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Accord Healthcare, Inc. for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Levothyroxine Sodium Tablets, USP (1000-count bottle)by Accord Healthcare, Inc.

Variants: 75 mcg (0.075 mg), Tablet

Lot Numbers:

D2300191 (Exp 12/31/2025)

NDC:

16729-449-17

Manufactured by Intas Pharmaceuticals Limited in India for Accord Healthcare, Inc.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 95747

Status: Active

Manufacturer: ACCORD HEALTHCARE, INC.

Sold By: Pharmacies

Manufactured In: India, United States

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg) sold in 1000-count bottles under NDC 16729-449-17.

Check the label of your prescription bottle for lot number D2300191 with an expiration date of 12/31/2025 to determine if your medication is part of the recall.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Accord Healthcare, Inc. for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.